Join
Live feed
·
INSIDERFilingvia Quantisnow
Relay Therapeutics Inc. logo

President and CEO Patel Sanjiv was granted 994 shares and sold $337,574 worth of shares (43,168 units at $7.82), decreasing direct ownership by 6% to 661,041 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RLAY· Relay Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RLAY (Relay Therapeutics Inc.) and more on Quantisnow.

President and CEO Patel Sanjiv was granted 994 shares and sold $337,574 worth of shares (43,168 units at $7.82), decreasing direct ownership by 6% to 661,041 units (SEC Form 4) | Quantisnow